Citations (126)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Julie Fu, Jenica Upshaw, Joshua Cohen, Angie Mae Rodday, Tully Saunders, Michael Kelly, Andrew M. Evens & Susan K. Parsons. (2018) Assessing the risk of cardiac toxicity after contemporary treatment for Hodgkin lymphoma: a systematic review. Leukemia & Lymphoma 59:8, pages 1976-1980.
Read now
Read now
Tineke Vandenbroucke, Magali Verheecke, Kristel Van Calsteren, Sileny Han, Laurence Claes & Frédéric Amant. (2014) Fetal outcome after prenatal exposure to chemotherapy and mechanisms of teratogenicity compared to alcohol and smoking. Expert Opinion on Drug Safety 13:12, pages 1653-1665.
Read now
Read now
Ming Hui Chen, Lauren H. Blackington, Jing Zhou, Tammy F. Chu, Kimberlee Gauvreau, Karen J. Marcus, David C. Fisher, Lisa R. Diller & Andrea K. Ng. (2014) Blood pressure is associated with occult cardiovascular disease in prospectively studied Hodgkin lymphoma survivors after chest radiation. Leukemia & Lymphoma 55:11, pages 2477-2483.
Read now
Read now
Bradford S. Hoppe, Stella Flampouri, Zuofeng Li & Nancy P. Mendenhall. (2010) Cardiac sparing with proton therapy in consolidative radiation therapy for Hodgkin lymphoma. Leukemia & Lymphoma 51:8, pages 1559-1562.
Read now
Read now
Dennis A. Eichenauer & Andreas Engert. (2009) Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma?. Leukemia & Lymphoma 50:11, pages 1733-1734.
Read now
Read now
Louis S. Constine. (2008) Cured of Hodgkin lymphoma, but suffering a broken heart. Leukemia & Lymphoma 49:8, pages 1433-1435.
Read now
Read now
Articles from other publishers (120)
Melanie Powis, Saidah Hack, Rouhi Fazelzad, David Hodgson & Vishal Kukreti. (2023) Survivorship care for patients curatively treated for Hodgkin’s and non-Hodgkin’s lymphoma: a scoping review. Journal of Cancer Survivorship.
Crossref
Crossref
Janet Bouttell, Heather Fraser, John R. Goodlad, David Hopkins, Pam McKay, Karin A. Oien, Bruce Seligmann, Stephan von Delft & Neil Hawkins. (2023) Adding a Gene Expression Profile Test to Aid Differential Diagnosis and Treatment in Aggressive Large B-Cell Lymphoma: An Early Exploratory Economic Evaluation. Applied Health Economics and Health Policy.
Crossref
Crossref
Peng Sun, Hang Yang, Yu Wang, Baitian Zhao, Man Nie, Kangming Huang & Zhiming Li. (2023) Tislelizumab monotherapy in patients with previously untreated early-stage classical Hodgkin lymphoma: a real-world study. Annals of Hematology.
Crossref
Crossref
Andrea Nathalie Rosas Diaz, Gabriel Pajares Hurtado, Abul Andres Ariza Manzano, Michelle J. Keyes, Cole Turissini, Arrush Choudhary, Casie Curtin, Sujithraj Dommaraju, Sarah Warack, Jordan B Strom & Aarti Asnani. (2023) Sex Differences in the Development of Anthracycline-Associated Heart Failure. Journal of Cardiac Failure.
Crossref
Crossref
Katja C E Drechsel, Maxime C F Pilon, Francis Stoutjesdijk, Salena Meivis, Linda J Schoonmade, William Hamish B Wallace, Eline van Dulmen-den Broeder, Auke Beishuizen, Gertjan J L Kaspers, Simone L Broer & Margreet A Veening. (2023) Reproductive ability in survivors of childhood, adolescent, and young adult Hodgkin lymphoma: a review. Human Reproduction Update 29:4, pages 486-517.
Crossref
Crossref
Kevin Agostinucci, Marianne K. O. Grant, Wongel Melaku, Chandini Nair & Beshay N. Zordoky. (2023) Exposure to Doxorubicin Modulates the Cardiac Response to Isoproterenol in Male and Female Mice. Pharmaceuticals 16:3, pages 391.
Crossref
Crossref
Simone de Vries, Miriam L. Haaksma, Katarzyna Jóźwiak, Michael Schaapveld, David C. Hodgson, Pieternella J. Lugtenburg, Augustinus D.G. Krol, Eefke J. Petersen, Dick Johan van Spronsen, Sameera Ahmed, Michael Hauptmann, Berthe M.P. Aleman & Flora E. van Leeuwen. (2023) Development and Validation of Risk Prediction Models for Coronary Heart Disease and Heart Failure After Treatment for Hodgkin Lymphoma. Journal of Clinical Oncology 41:1, pages 86-95.
Crossref
Crossref
Neil A. Bradbury. 2023. Principles of Gender-Specific Medicine. Principles of Gender-Specific Medicine
231
264
.
Karan L. Chohan, Jason R. Young, Scott Lester, Muhamad Alhaj Moustafa, Allison Rosenthal, Han W. Tun, Bradford S. Hoppe, Patrick B. Johnston, Ivana N. Micallef, Thomas M. Habermann & Stephen M. Ansell. (2022) A real-world study of combined modality therapy for early-stage Hodgkin lymphoma: too little treatment impacts outcome. Blood Advances 6:14, pages 4241-4250.
Crossref
Crossref
Maja V Maraldo, Mario Levis, Alessandro Andreis, Saro Armenian, James Bates, Jessica Brady, Alessandra Ghigo, Alexander R Lyon, Charlotte Manisty, Umberto Ricardi, Marianne C Aznar & Andrea Riccardo Filippi. (2022) An integrated approach to cardioprotection in lymphomas. The Lancet Haematology 9:6, pages e445-e454.
Crossref
Crossref
Elissa A. S. Polomski, Julius C. Heemelaar, Augustinus D. G. Krol, Marloes Louwerens, Saskia L. M. A. Beeres, Eduard R. Holman, J. Wouter Jukema, Martin J. Schalij & M. Louisa Antoni. (2022) Impaired Global Longitudinal Strain Is Associated with Cardiovascular Events in Hodgkin Lymphoma Survivors. Cancers 14:9, pages 2329.
Crossref
Crossref
Ingemar Lagerlöf, Helena Fohlin, Gunilla Enblad, Bengt Glimelius, Christina Goldkuhl, Marzia Palma, Lisa Åkesson, Ingrid Glimelius & Daniel Molin. (2022) Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy. Journal of Clinical Oncology 40:13, pages 1487-1496.
Crossref
Crossref
Bachir Bachir, Sirine Anouti, Joseph Abi Jaoude, Majd Kayali, Arafat Tfayli, Evandro de Azambuja, Philip Poortmans & Youssef H. Zeidan. (2022) Evaluation of Cardiotoxicity in HER-2-Positive Breast Cancer Patients Treated With Radiation Therapy and Trastuzumab. International Journal of Radiation Oncology*Biology*Physics 113:1, pages 135-142.
Crossref
Crossref
Efstratios Koutroumpakis, Anita Deswal, Syed Wamique Yusuf, Jun-ichi Abe, Kevin T. Nead, Adam S. Potter, Zhongxing Liao, Steven H. Lin & Nicolas L. Palaskas. (2022) Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment. Current Oncology Reports 24:5, pages 543-553.
Crossref
Crossref
Nicholas S. Wilcox, Seth J. Rotz, McKay MullenEvelyn J. SongBetty Ky HamiltonJavid Moslehi, Saro H. Armenian, Joseph C. Wu, June-Wha RheeBonnie Ky. (2022) Sex-Specific Cardiovascular Risks of Cancer and Its Therapies. Circulation Research 130:4, pages 632-651.
Crossref
Crossref
Rachel Murphy-Banks, Anita J. Kumar, Mingqian Lin, Nicole Savidge, Emma Livne & Susan K. Parsons. (2021) Hodgkin lymphoma survivor perspectives on their engagement in treatment decision-making and discussion of late effects. Supportive Care in Cancer 30:2, pages 1399-1405.
Crossref
Crossref
Mohamed Riad Abdelgawad Abouzid, Maha Hameed, Maanya Rajasree Katta & Sai Sudha Valisekka. (2022) Approach to Lymphoma-Associated Cardiomyopathy. Cardiology in Review Publish Ahead of Print.
Crossref
Crossref
Anita J. Kumar, Rachel Murphy-Banks, Ruth Ann Weidner & Susan K. Parsons. (2022) Perceptions of Role in Treatment Decision Making and Understanding of Late Effects Among Hodgkin Lymphoma Survivors: Results From a National Survey HL Decision Making and Late Effects. Clinical Lymphoma Myeloma and Leukemia 22:1, pages e65-e69.
Crossref
Crossref
Navin Kumar, Swagata Chatterjee & Bhavna Solanki. 2022. Cardiovascular toxicity and therapeutic modalities targeting cardio-oncology. Cardiovascular toxicity and therapeutic modalities targeting cardio-oncology
165
193
.
Jie Gao, Yingying Chen, Pengqiang Wu, Fujue Wang, Huan Tao, Qianqing Shen, Shuoting Wang, Shuaige Gong, Xue Zhang, Zhencang Zhou, Xianmin Song & Yongqian Jia. (2021) Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis. BMC Cancer 21:1.
Crossref
Crossref
David J. Cutter, Johanna Ramroth, Patricia Diez, Andy Buckle, Georgios Ntentas, Bilyana Popova, Laura Clifton-Hadley, Peter J. Hoskin, Sarah C. Darby, John Radford & Tim Illidge. (2021) Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography–Directed Therapy for Early-Stage Hodgkin Lymphoma. Journal of Clinical Oncology 39:32, pages 3591-3601.
Crossref
Crossref
Michela Buglione, Andrea Emanuele Guerini, Andrea Riccardo Filippi, Luigi Spiazzi, Nadia Pasinetti, Alessandro Magli, Cristian Toraci, Paolo Borghetti, Luca Triggiani, Alessandro Alghisi, Gianluca Costantino, Francesco Bertagna, Niccolò Giaj Levra, Ludovica Pegurri & Stefano Maria Magrini. (2021) A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin’s Lymphoma. Critical Reviews in Oncology/Hematology 167, pages 103437.
Crossref
Crossref
Abhenil Mittal, Sainath Bhethanabhotla, Shuvadeep Ganguly, Sreenivas Vishnubhatla, Rajesh Khadgawat, Chetan Patel, Anant Mohan, Ahitagni Biswas & Sameer Bakhshi. (2021) Late effects in pediatric Hodgkin lymphoma survivors after uniform treatment with ABVD with or without radiotherapy. Pediatric Blood & Cancer 68:11.
Crossref
Crossref
Nadine Norton, Raegan M. Weil & Pooja P. Advani. (2021) Inter-Individual Variation and Cardioprotection in Anthracycline-Induced Heart Failure. Journal of Clinical Medicine 10:18, pages 4079.
Crossref
Crossref
Anna Warhol, Sharon A. George, Sofian N. Obaid, Tatiana Efimova & Igor R. Efimov. (2021) Differential cardiotoxic electrocardiographic response to doxorubicin treatment in conscious versus anesthetized mice. Physiological Reports 9:15.
Crossref
Crossref
Simone de Vries, Michael Schaapveld, Cécile P M Janus, Laurien A Daniëls, Eefke J Petersen, Richard W M van der Maazen, Josée M Zijlstra, Max Beijert, Marten R Nijziel, Karijn M S Verschueren, Leontien C M Kremer, Anna M van Eggermond, Pieternella J Lugtenburg, Augustinus D G Krol, Judith M Roesink, Wouter J Plattel, Dick Johan van Spronsen, Gustaaf W van Imhoff, Jan Paul de Boer, Berthe M P Aleman & Flora E van Leeuwen. (2021) Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients. JNCI: Journal of the National Cancer Institute 113:6, pages 760-769.
Crossref
Crossref
Alicia Rovó & André Tichelli. 2021. Blood and Marrow Transplantation Long Term Management. Blood and Marrow Transplantation Long Term Management
241
250
.
Siddhartha Yadav, Karthik V. Giridhar, Kathryn J. Ruddy & Roberto A. Leon-Ferre. 2021. Common Issues in Breast Cancer Survivors. Common Issues in Breast Cancer Survivors
319
328
.
Andrew M. Evens & Susan K. Parsons. (2020) Continuum of Care for Hodgkin Lymphoma: Impact of Modern Therapy on Postacute Morbidity and Mortality. Journal of Clinical Oncology 38:35, pages 4131-4134.
Crossref
Crossref
Irma Bisceglia, Maria Laura Canale, Chiara Lestuzzi, Iris Parrini, Giulia Russo, Furio Colivicchi, Domenico Gabrielli, Michele Massimo Gulizia & Cezar A. Iliescu. (2020) Acute coronary syndromes in cancer patients. Journal of Cardiovascular Medicine 21:12, pages 944-952.
Crossref
Crossref
Ibrahim N. Muhsen, Merav Bar, Bipin N. Savani, Elihu H. Estey & Shahrukh K. Hashmi. (2020) Follow-up issues in survivors of hematologic malignancies – Current stance and future perspectives. Blood Reviews 44, pages 100674.
Crossref
Crossref
Lisa Kim, Emefah C. Loccoh, Reynaldo Sanchez, Patrick Ruz, Uzoma Anaba, Terence M. Williams, Jeremy Slivnick, Ajay Vallakati, Ragavendra Baliga, Ahmet Ayan, Eric D. Miller & Daniel Addison. (2020) Contemporary Understandings of Cardiovascular Disease After Cancer Radiotherapy: a Focus on Ischemic Heart Disease. Current Cardiology Reports 22:11.
Crossref
Crossref
Sharon A. George, Alexi Kiss, Sofian N. Obaid, Aileen Venegas, Trisha Talapatra, Chapman Wei, Tatiana Efimova & Igor R. Efimov. (2020) p38δ genetic ablation protects female mice from anthracycline cardiotoxicity. American Journal of Physiology-Heart and Circulatory Physiology 319:4, pages H775-H786.
Crossref
Crossref
Rachel A. Schlaak, Anne Frei, Brian L. Fish, Leanne Harmann, Tracy Gasperetti, Jamie L. Pipke, Yunguang Sun, Hallgeir Rui, Michael J. Flister, Benjamin N. Gantner & Carmen Bergom. (2020) Acquired Immunity Is Not Essential for Radiation-Induced Heart Dysfunction but Exerts a Complex Impact on Injury. Cancers 12:4, pages 983.
Crossref
Crossref
Elizabeth M. Nichols, Arezoo Modiri & Pranshu Mohindra. (2020) Cardiotoxicity and Radiation Therapy: A Review of Clinical Impact in Breast and Thoracic Malignancies. Applied Radiation Oncology, pages 16-23.
Crossref
Crossref
Ingemar Lagerlöf, Harald Holte, Ingrid Glimelius, Magnus Björkholm, Gunilla Enblad, Martin Erlanson, Øystein Fluge, Helena Fohlin, Alexander Fosså, Christina Goldkuhl, Anita Gustavsson, Ann‐Sofie Johansson, Johan Linderoth, Ole Nome, Marzia Palma, Lisa Åkesson, Bjørn Østenstad, Cecilia Raud, Bengt Glimelius & Daniel Molin. (2019) No excess long‐term mortality in stage I‐IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy. British Journal of Haematology 188:5, pages 685-691.
Crossref
Crossref
Efstratios Koutroumpakis, Nicolas L. Palaskas, Steven H. Lin, Jun-ichi Abe, Zhongxing Liao, Jose Banchs, Anita Deswal & Syed Wamique Yusuf. (2020) Modern Radiotherapy and Risk of Cardiotoxicity. Chemotherapy 65:3-4, pages 65-76.
Crossref
Crossref
Berthe M. P. Aleman & David J. Cutter. 2020. Hodgkin Lymphoma. Hodgkin Lymphoma
465
483
.
Susan K. Parsons, Joshua T. Cohen & Andrew M. Evens. 2020. Hodgkin Lymphoma. Hodgkin Lymphoma
265
273
.
Alexander Fosså, René-Olivier Casasnovas & Peter W. M. Johnson. 2020. Hodgkin Lymphoma. Hodgkin Lymphoma
249
264
.
Christian Cadeddu Dessalvi, Alessia Pepe, Claudia Penna, Alessia Gimelli, Rosalinda Madonna, Donato Mele, Ines Monte, Giuseppina Novo, Cinzia Nugara, Concetta Zito, Javid J Moslehi, Rudolf A de Boer, Alexander R. Lyon, Carlo Gabriele Tocchetti & Giuseppe Mercuro. (2019) Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens. Heart Failure Reviews 24:6, pages 915-925.
Crossref
Crossref
Chelsea R. Stone, Alexis T. Mickle, Devon J. Boyne, Aliya Mohamed, Doreen M. Rabi, Darren R. Brenner & Christine M. Friedenreich. (2019) Treatment for lymphoma and late cardiovascular disease risk: A systematic review and meta‐analysis. Health Science Reports 2:10.
Crossref
Crossref
Caroline E. Weibull, Magnus Björkholm, Ingrid Glimelius, Paul C. Lambert, Therese M. L. Andersson, Karin E. Smedby, Paul W. Dickman & Sandra Eloranta. (2019) Temporal trends in treatment‐related incidence of diseases of the circulatory system among Hodgkin lymphoma patients. International Journal of Cancer 145:5, pages 1200-1208.
Crossref
Crossref
Ingrid Glimelius, Annika Englund, Klaus Rostgaard, Karin E. Smedby, Sandra Eloranta, Peter de Nully Brown, Christoffer Johansen, Peter Kamper, Gustaf Ljungman, Lisa Lyngsie Hjalgrim & Henrik Hjalgrim. (2019) Distribution of hospital care among pediatric and young adult Hodgkin lymphoma survivors—A population‐based cohort study from Sweden and Denmark. Cancer Medicine 8:10, pages 4918-4927.
Crossref
Crossref
Steven M. Bair & Jakub Svoboda. (2019) Response-Adapted Treatment Strategies in Hodgkin Lymphoma Using PET Imaging. PET Clinics 14:3, pages 353-368.
Crossref
Crossref
Despoina-Rafailia Benetou, Evangelos Stergianos, Maria Geropeppa, Erato Ntinopoulou, Marina Tzanni, Apostolos Pourtsidis, Andreas C. Petropoulos, Marios K. Georgakis, Dimitrios Tousoulis & Eleni Th Petridou. (2019) Late-onset cardiomyopathy among survivors of childhood lymphoma treated with anthracyclines: a systematic review. Hellenic Journal of Cardiology 60:3, pages 152-164.
Crossref
Crossref
Moussab Damlaj, Riad El Fakih & Shahrukh K. Hashmi. (2019) Evolution of survivorship in lymphoma, myeloma and leukemia: Metamorphosis of the field into long term follow-up care. Blood Reviews 33, pages 63-73.
Crossref
Crossref
Maya Wiessman, Dorit Leshem, Moshe Yeshurun, Hagai Yavin, Zaza Iakobishvilli, Pia Raanani, Ran Kornowski, Eli I. Lev & Mordehay Vaturi. (2018) Dysfunctional endothelial progenitor cells in patients with Hodgkin’s lymphoma in complete remission. Cancer Medicine 8:1, pages 305-310.
Crossref
Crossref
Becky Meiners, Chetan Shenoy & Beshay N. Zordoky. (2018) Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity. Biology of Sex Differences 9:1.
Crossref
Crossref
Helena C. Besse, Clemens Bos, Maurice M. J. M. Zandvliet, Kim van der Wurff-Jacobs, Chrit T. W. Moonen & Roel Deckers. (2018) Triggered radiosensitizer delivery using thermosensitive liposomes and hyperthermia improves efficacy of radiotherapy: An in vitro proof of concept study. PLOS ONE 13:9, pages e0204063.
Crossref
Crossref
Vivian Y. Chang & Jessica J. Wang. (2018) Pharmacogenetics of Chemotherapy-Induced Cardiotoxicity. Current Oncology Reports 20:7.
Crossref
Crossref
Simone de Vries, Michael Schaapveld, Frederika A van Nimwegen, Katarzyna Jóźwiak, Pieternella J Lugtenburg, Laurien A Daniëls, Judith M Roesink, Richard W M van der Maazen, Wouter E M Kok, Berthe M P Aleman & Flora E van Leeuwen. (2018) High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors. British Journal of Cancer 118:6, pages 887-895.
Crossref
Crossref
Wendy Landier & Smita Bhatia. 2018. Hematology. Hematology
1496
1512.e8
.
Marianne K. O. Grant, Davis M. Seelig, Leslie C. Sharkey & Beshay N. Zordoky. (2017) Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice. Biology of Sex Differences 8:1.
Crossref
Crossref
Gaurav Goyal, Edward B. Maldonado, Tiffany J. Fan, Arun Kanmanthareddy, Peter T. Silberstein, Ronald S. Go & James O. Armitage. (2017) Treatment Patterns and Outcomes in Early-stage Hodgkin Lymphoma in the Elderly: A National Cancer Database Analysis. Clinical Lymphoma Myeloma and Leukemia 17:12, pages 812-818.
Crossref
Crossref
Carmen Chan, Bernard Law, Winnie So, Ka Chow & Mary Waye. (2017) Novel Strategies on Personalized Medicine for Breast Cancer Treatment: An Update. International Journal of Molecular Sciences 18:11, pages 2423.
Crossref
Crossref
Mohammad Fahim ur Rehman. (2017) Incidence of Cardiotoxicity in Treated Cases of Paediatric Hodgkin Lymphoma. Hematology & Transfusion International Journal 5:4.
Crossref
Crossref
Merrill H. Stewart, Eiman Jahangir & Nichole M. Polin. (2017) Valvular Heart Disease in Cancer Patients: Etiology, Diagnosis, and Management. Current Treatment Options in Cardiovascular Medicine 19:7.
Crossref
Crossref
Kathrine Rugbjerg, Maja Maraldo, Marianne C. Aznar, David J. Cutter, Sarah C. Darby, Lena Specht & Jørgen H. Olsen. (2017) Long-term hospitalisation rates among 5-year survivors of Hodgkin lymphoma in adolescence or young adulthood: A nationwide cohort study. International Journal of Cancer 140:10, pages 2232-2245.
Crossref
Crossref
Frederika A. van NimwegenGeorgios NtentasSarah C. DarbyMichael SchaapveldMichael HauptmannPieternella J. Lugtenburg, Cecile P. M. JanusLaurien DanielsFlora E. van LeeuwenDavid J. Cutter & Berthe M. P. Aleman. (2017) Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines. Blood 129:16, pages 2257-2265.
Crossref
Crossref
Ingrid Glimelius, Sandra Eloranta, Sara Ekberg, Ellen T. Chang, Martin Neovius & Karin E. Smedby. (2017) Increased healthcare use up to 10 years among relapse‐free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy. American Journal of Hematology 92:3, pages 251-258.
Crossref
Crossref
B. Fresneau, C. Fayech, T. Butel, N. Haddy, D. Valteau-Couanet & P. Ou. (2017) Facteurs de risque et surveillance ? long terme des complications cardiaques apr?s traitement pour un cancer pendant l?enfance. La Revue de M?decine Interne 38:2, pages 125-132.
Crossref
Crossref
Flora E. van Leeuwen & Andrea K. Ng. (2016) Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment. Hematology 2016:1, pages 323-330.
Crossref
Crossref
Beshay N. Zordoky, M. Judith Radin, Lois Heller, Anthony Tobias, Ilze Matise, Fred S. Apple, Sylvia A. McCune & Leslie C. Sharkey. (2016) The interplay between genetic background and sexual dimorphism of doxorubicin-induced cardiotoxicity. Cardio-Oncology 2:1.
Crossref
Crossref
Nickhill Bhakta, Qi Liu, Frederick Yeo, Malek Baassiri, Matthew J Ehrhardt, Deo K Srivastava, Monika L Metzger, Matthew J Krasin, Kirsten K Ness, Melissa M Hudson, Yutaka Yasui & Leslie L Robison. (2016) Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study. The Lancet Oncology 17:9, pages 1325-1334.
Crossref
Crossref
Barbora Pitekova, Sriram Ravi, Shimoli V. Shah, Beata Mladosievicova, Stephen Heitner & Maros Ferencik. (2016) The Role of Imaging with Cardiac Computed Tomography in Cardio-Oncology Patients. Current Cardiology Reports 18:9.
Crossref
Crossref
Andrea K. Ng & Flora E. van Leeuwen. (2016) Hodgkin lymphoma: Late effects of treatment and guidelines for surveillance. Seminars in Hematology 53:3, pages 209-215.
Crossref
Crossref
Mark T. Nolan, David J. Russell & Thomas H. Marwick. (2016) Long-term Risk of Heart Failure and Myocardial Dysfunction After Thoracic Radiotherapy: A Systematic Review. Canadian Journal of Cardiology 32:7, pages 908-920.
Crossref
Crossref
Arya AminiBlair MurphyCarrye R. CostTimothy P. GarringtonBrian S. GreffeArthur K. Liu. (2016) Cardiac Mortality in Children and Adolescents with Hodgkin's Lymphoma: A Surveillance, Epidemiology and End Results Analysis. Journal of Adolescent and Young Adult Oncology 5:2, pages 181-186.
Crossref
Crossref
Ryan C. LynchRanjana H. Advani. (2016) Risk-Adapted Treatment of Advanced Hodgkin Lymphoma With PET-CT. American Society of Clinical Oncology Educational Book:36, pages e376-e385.
Crossref
Crossref
Konstantinos Marmagkiolis, William Finch, Despina Tsitlakidou, Tyler Josephs, Cezar Iliescu, John F. Best & Eric H. Yang. (2016) Radiation Toxicity to the Cardiovascular System. Current Oncology Reports 18:3.
Crossref
Crossref
Melissa R. Hines, Daniel A. Mulrooney, Melissa M. Hudson, Kirsten K. Ness, Daniel M. Green, Scott C. Howard, Matthew Krasin & Monika L. Metzger. (2015) Pregnancy-associated cardiomyopathy in survivors of childhood cancer. Journal of Cancer Survivorship 10:1, pages 113-121.
Crossref
Crossref
Frederika A. van NimwegenMichael SchaapveldDavid J. CutterCècile P.M. JanusAugustinus D.G. KrolMichael HauptmannKaren KooijmanJudith RoesinkRichard van der MaazenSarah C. DarbyBerthe M.P. AlemanFlora E. van Leeuwen. (2016) Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma. Journal of Clinical Oncology 34:3, pages 235-243.
Crossref
Crossref
Gaurav Goyal, Peter T. Silberstein & James O. Armitage. (2016) Trends in Use of Radiation Therapy for Hodgkin Lymphoma From 2000 to 2012 on the Basis of the National Cancer Data Base. Clinical Lymphoma Myeloma and Leukemia 16:1, pages 12-17.
Crossref
Crossref
Kenneth B. Roberts, Kara M. Kelly & Louis S. Constine. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology
1464
1485.e5
.
Maja V Maraldo, Francesco Giusti, Ivan R Vogelius, Michael Lundemann, Marleen A E van der Kaaij, Safaa Ramadan, Bart Meulemans, Michel Henry-Amar, Berthe M P Aleman, John Raemaekers, Paul Meijnders, Elisabeth C Moser, Hanneke C Kluin-Nelemans, Pierre Feugier, Olivier Casasnovas, Catherine Fortpied & Lena Specht. (2015) Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials. The Lancet Haematology 2:11, pages e492-e502.
Crossref
Crossref
David J. Iberri, Richard T. Hoppe & Ranjana H. Advani. (2015) Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease?the Role of Functional Imaging. Current Treatment Options in Oncology 16:9.
Crossref
Crossref
Anthony F Yu & Lee W Jones. (2015) Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic training. Future Cardiology 11:4, pages 441-452.
Crossref
Crossref
David J. Cutter, Michael Schaapveld, Sarah C. Darby, Michael Hauptmann, Frederika A. van Nimwegen, Augustinus D. G. Krol, Cecile P. M. Janus, Flora E. van Leeuwen & Berthe M. P. Aleman. (2015) Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma. JNCI: Journal of the National Cancer Institute 107:4.
Crossref
Crossref
Michael CrumpJordan HerstFulvia BaldassarreJonathan SussmanJanet MacEachern, David HodgsonMatthew C. Cheung. (2015) Evidence-based focused review of the role of radiation therapy in the treatment of early-stage Hodgkin lymphoma. Blood 125:11, pages 1708-1716.
Crossref
Crossref
M. J. Matasar, J. S. Ford, E. R. Riedel, T. Salz, K. C. Oeffinger & D. J. Straus. (2015) Late Morbidity and Mortality in Patients with Hodgkin's Lymphoma Treated During Adulthood. JNCI Journal of the National Cancer Institute 107:4, pages djv018-djv018.
Crossref
Crossref
Berthe M. P. Aleman & David J. Cutter. 2015. Hodgkin Lymphoma. Hodgkin Lymphoma
411
425
.
Michael S. Ewer. 2015. Advances in Cancer Survivorship Management. Advances in Cancer Survivorship Management
325
334
.
Maria Alma Rodriguez, Leslie Ballas & Kristin Simar. 2015. Advances in Cancer Survivorship Management. Advances in Cancer Survivorship Management
201
218
.
Th?odore Girinsky. (2014) In Reply to Gyenes. International Journal of Radiation Oncology*Biology*Physics 89:4, pages 931-932.
Crossref
Crossref
Berthe M.P. Aleman, Elizabeth C. Moser, Janine Nuver, Thomas M. Suter, Maja V. Maraldo, Lena Specht, Conny Vrieling & Sarah C. Darby. (2014) Cardiovascular disease after cancer therapy. European Journal of Cancer Supplements 12:1, pages 18-28.
Crossref
Crossref
Theodore Girinsky, Radhia M?Kacher, Nathalie Lessard, Serge Koscielny, Eric Elfassy, Fran?ois Raoux, Patrice Carde, Marcos Dos Santos, Jean-Pierre Margainaud, Laure Sabatier, Mithra Ghalibafian & Jean-Fran?ois Paul. (2014) Prospective Coronary Heart Disease Screening in Asymptomatic Hodgkin Lymphoma Patients Using Coronary Computed Tomography Angiography: Results and Risk Factor Analysis. International Journal of Radiation Oncology*Biology*Physics 89:1, pages 59-66.
Crossref
Crossref
Berthe M. P. Aleman, Lena Specht & Ming Hui Chen. 2014. ALERT • Adverse Late Effects of Cancer Treatment. ALERT • Adverse Late Effects of Cancer Treatment
287
323
.
Richard M. Steingart, Nandini Yadav, Carlos Manrique, Joseph R. Carver & Jennifer Liu. (2013) Cancer Survivorship: Cardiotoxic Therapy in the Adult Cancer Patient; Cardiac Outcomes With Recommendations for Patient Management. Seminars in Oncology 40:6, pages 690-708.
Crossref
Crossref
Marzia Lotrionte, Giuseppe Biondi-Zoccai, Antonio Abbate, Gaetano Lanzetta, Fabrizio D'Ascenzo, Vincenzo Malavasi, Mariangela Peruzzi, Giacomo Frati & Giovanni Palazzoni. (2013) Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity. The American Journal of Cardiology 112:12, pages 1980-1984.
Crossref
Crossref
Alicia Rovó & André Tichelli. 2013. Blood and Marrow Transplantation Long-Term Management. Blood and Marrow Transplantation Long-Term Management
244
257
.
Manuel Gotti, Valeria Fiaccadori, Elisa Bono, Benedetta Landini, Marzia Varettoni, Luca Arcaini & Maurizio Bonfichi. (2013) Therapy-Related Late Adverse Events in Hodgkin’s Lymphoma. Lymphoma 2013, pages 1-7.
Crossref
Crossref
Arthur Olch. 2013. Pediatric Radiotherapy Planning and Treatment. Pediatric Radiotherapy Planning and Treatment
169
204
.
Leo I. GordonFangxin HongRichard I. FisherNancy L. BartlettJoseph M. ConnorsRandy D. GascoyneHenry WagnerPatrick J. StiffBruce D. ChesonMary GospodarowiczRanjana AdvaniBrad S. KahlJonathan W. FriedbergKristie A. BlumThomas M. HabermannJoseph M. TuscanoRichard T. HoppeSandra J. Horning. (2013) Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496). Journal of Clinical Oncology 31:6, pages 684-691.
Crossref
Crossref
Chris R. Kelsey & Lynn D. Wilson. 2014. Decision Tools for Radiation Oncology. Decision Tools for Radiation Oncology
257
278
.
Saurabh Dahiya, Wei B. Ooi, Jaya Mallidi, Senthil Sivalingam & Richard Steingart. (2017) Primary Testicular Lymphoma with Cardiac Involvement in an Immunocompetent Patient: Case Report and a Concise Review of Literature. Rare Tumors 4:3, pages 138-140.
Crossref
Crossref
Ronny S. Jiji, Christopher M. Kramer & Michael Salerno. (2012) Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs. Journal of Nuclear Cardiology 19:2, pages 377-388.
Crossref
Crossref
F.A. Stewart, A.V. Akleyev, M. Hauer-Jensen, J.H. Hendry, N.J. Kleiman, T.J. MacVittie, B.M. Aleman, A.B. Edgar, K. Mabuchi, C.R. Muirhead, R.E. Shore & W.H. Wallace. (2012) ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context. Annals of the ICRP 41:1-2, pages 1-322.
Crossref
Crossref
Florentine S.M. Hilbers, Naomi B. Boekel, Alexandra J. van den Broek, Richard van Hien, Sten Cornelissen, Berthe M.P. Aleman, Laura J. van ’t Veer, Flora E. van Leeuwen & Marjanka K. Schmidt. (2012) Genetic variants in TGFβ-1 and PAI-1 as possible risk factors for cardiovascular disease after radiotherapy for breast cancer. Radiotherapy and Oncology 102:1, pages 115-121.
Crossref
Crossref
David C. Hodgson. (2011) Late Effects in the Era of Modern Therapy for Hodgkin Lymphoma. Hematology 2011:1, pages 323-329.
Crossref
Crossref
. (2011) ABVD versus BEACOPP for Hodgkin's Lymphoma. New England Journal of Medicine 365:16, pages 1544-1546.
Crossref
Crossref
Elena M. van Leeuwen-Segarceanu, Willem-Jan W. Bos, Lucille D.A. Dorresteijn, Benno J.W.M. Rensing, Jan A.S. van der Heyden, Oscar J.M. Vogels & Douwe H. Biesma. (2011) Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease. Cancer Treatment Reviews 37:5, pages 391-403.
Crossref
Crossref
Andrea K. Ng. (2011) Review of the cardiac long-term effects of therapy for Hodgkin lymphoma. British Journal of Haematology 154:1, pages 23-31.
Crossref
Crossref
J.K. Raikhelkar, R.M. Steingart & C.L. Chen. (2011) Role of echocardiography in cancer careRolle der Echokardiographie in der Behandlung und Betreuung von Krebspatienten. Herz 36:4, pages 333-339.
Crossref
Crossref
Andrea K. NgAnn LaCasceLois B. Travis. (2011) Long-Term Complications of Lymphoma and Its Treatment. Journal of Clinical Oncology 29:14, pages 1885-1892.
Crossref
Crossref
Frédéric Poulin, Alexandre Semionov, Philippe Roméo, Philippe Demers, Josephine Pressacco & Arsène Basmadjian. (2011) Extensive Radiation-Induced Heart Disease in an Adult Patient Treated for Lymphoma as a Child. Canadian Journal of Cardiology 27:3, pages 390.e1-390.e4.
Crossref
Crossref
Ming Hui ChenSteven D. ColanLisa Diller. (2011) Cardiovascular Disease. Circulation Research 108:5, pages 619-628.
Crossref
Crossref
Shira L. GalperJames B. YuPeter M. MauchJon F. StrasserBarbara SilverAnn LaCasceKaren J. MarcusMary Ann Stevenson, Ming Hui Chen & Andrea K. Ng. (2011) Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood 117:2, pages 412-418.
Crossref
Crossref
Berthe M. P. Aleman. 2011. Hodgkin Lymphoma. Hodgkin Lymphoma
333
344
.
F. A. Stewart, S. Hoving & N. S. Russell. (2010) Vascular Damage as an Underlying Mechanism of Cardiac and Cerebral Toxicity in Irradiated Cancer Patients. Radiation Research 174:6b, pages 865-869.
Crossref
Crossref
Nicolas Magné, Cyrus Chargari, Dhara MacDermed, Rosa Conforti, Lionel Védrine, Jean-Philippe Spano & David Khayat. (2010) Tomorrow's targeted therapies in breast cancer patients: What is the risk for increased radiation-induced cardiac toxicity?. Critical Reviews in Oncology/Hematology 76:3, pages 186-195.
Crossref
Crossref
Melania Pintilie, Yan Bai, Lingsong Yun & David C. Hodgson. (2010) The analysis of case cohort design in the presence of competing risks with application to estimate the risk of delayed cardiac toxicity among Hodgkin Lymphoma survivors. Statistics in Medicine 29:27, pages 2802-2810.
Crossref
Crossref
Daniel Gomez & Ritsuko Komaki. (2010) Technical Advances of Radiation Therapy for Thymic Malignancies. Journal of Thoracic Oncology 5:10, pages S336-S343.
Crossref
Crossref
Sten Myrehaug, Melania PintilieLingsong YunMichael CrumpRichard W. Tsang, Ralph M. MeyerJonathan SussmanEric Yu & David C. Hodgson. (2010) A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart disease. Blood 116:13, pages 2237-2240.
Crossref
Crossref
Michele C. Walsh. (2010) Impact of Treatment-Related Cardiac Toxicity on Lymphoma Survivors: An Institutional Approach for Risk Reduction and Management. Clinical Journal of Oncology Nursing 14:4, pages 505-507.
Crossref
Crossref
David C. Hodgson, Eva Grunfeld, Nadia Gunraj & Lisa Del Giudice. (2010) A population-based study of follow-up care for Hodgkin lymphoma survivors. Cancer 116:14, pages 3417-3425.
Crossref
Crossref
Sarah C. Darby, David J. Cutter, Marjan Boerma, Louis S. Constine, Luis F. Fajardo, Kazunori Kodama, Kiyohiko Mabuchi, Lawrence B. Marks, Fred A. Mettler, Lori J. Pierce, Klaus R. Trott, Edward T.H. Yeh & Roy E. Shore. (2010) Radiation-Related Heart Disease: Current Knowledge and Future Prospects. International Journal of Radiation Oncology*Biology*Physics 76:3, pages 656-665.
Crossref
Crossref
Damien C. Weber, Nicolas Peguret, Giovanna Dipasquale & Luca Cozzi. (2009) Involved-Node and Involved-Field Volumetric Modulated Arc vs. Fixed Beam Intensity-Modulated Radiotherapy for Female Patients With Early-Stage Supra-Diaphragmatic Hodgkin Lymphoma: A Comparative Planning Study. International Journal of Radiation Oncology*Biology*Physics 75:5, pages 1578-1586.
Crossref
Crossref
Aileen B. ChenRinaa S. PungliaKaren M. KuntzPeter M. MauchAndrea K. Ng. (2009) Cost Effectiveness and Screening Interval of Lipid Screening in Hodgkin's Lymphoma Survivors. Journal of Clinical Oncology 27:32, pages 5383-5389.
Crossref
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:2.
Crossref
Crossref